| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.29B | 18.18B | 17.24B | 15.68B | 14.05B | 13.73B |
| Gross Profit | 8.42B | 7.98B | 7.70B | 6.97B | 5.91B | 5.91B |
| EBITDA | 2.64B | 3.33B | 2.90B | 2.91B | 2.00B | 3.10B |
| Net Income | 1.87B | 1.67B | 1.41B | 1.43B | 822.00M | 1.56B |
Balance Sheet | ||||||
| Total Assets | 85.65B | 86.35B | 81.94B | 79.20B | 75.57B | 81.63B |
| Cash, Cash Equivalents and Short-Term Investments | 6.12B | 8.56B | 7.67B | 5.89B | 43.08B | 49.85B |
| Total Debt | 8.93B | 9.49B | 8.94B | 9.00B | 9.02B | 9.08B |
| Total Liabilities | 66.06B | 66.71B | 64.01B | 62.67B | 60.37B | 62.45B |
| Stockholders Equity | 18.70B | 18.69B | 17.07B | 15.70B | 14.35B | 17.85B |
Cash Flow | ||||||
| Free Cash Flow | 2.18B | 2.70B | 2.39B | 3.22B | 2.65B | 2.14B |
| Operating Cash Flow | 2.80B | 3.28B | 3.02B | 3.91B | 3.31B | 2.62B |
| Investing Cash Flow | -1.63B | -2.83B | -1.98B | -2.75B | -2.35B | -1.19B |
| Financing Cash Flow | -707.00M | -513.00M | -898.00M | -1.30B | -1.04B | -1.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $26.00B | 22.22 | 17.98% | 2.10% | 17.87% | 90.86% | |
77 Outperform | $25.14B | 12.62 | 19.48% | 1.88% | 6.61% | 9.14% | |
76 Outperform | $11.36B | 13.92 | 18.76% | 6.71% | -1.65% | 10.67% | |
68 Neutral | $23.25B | -25.32 | 9.84% | ― | 2.96% | 1.82% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $22.40B | 9.62 | 10.21% | 0.23% | 4.17% | 29.30% | |
65 Neutral | $11.92B | 9.61 | 11.94% | 8.03% | 4.05% | 35.90% |